Clinical Trials Directory

Trials / Unknown

UnknownNCT05292729

Cognitive Function and Brain Connectivity in CAS Patients:a Rs-fMRI Study

Cognitive Function and Brain Connectivity in Carotid Artery Stenting Patients:a Rs-fMRI Study

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
First Affiliated Hospital of Zhejiang University · Academic / Other
Sex
All
Age
55 Years – 80 Years
Healthy volunteers
Accepted

Summary

This is a prospective study aimed to explore the changes of cognitive function after surgery for CAS and the correlation with brain connectivity, in order to look for the clinical biomarkers to predict the carotid stent implantation for patients which can effect the cognition

Detailed description

Carotid artery stenting (CAS) can significantly decrease the incidence of ischemic stroke in patients with severe carotid artery stenosis has been confirmed in large randomized controlled studies (1, 2).Previous studies showed carotid artery stenosis is closely related to cognitive dysfunction, including asymptomatic carotid artery stenosis(≥70%).Cognitive impairment is one of the most serious problem facing the elderly. The impact on cognitive function in patients with CAS has been discussed by many researchers, however the effect still remained conflicting. In past few years, several imaging techniques, such as resting-state functional MRI (R-fMRI), had been increasingly used to study cognitive impairment in humans. In this study, we evaluated the cognition performance in severe carotid artery stenosis patients undergoing CAS and explored the mechanisms underlying the cognition changes by the Rs-fMRI. Inclusion criteria: * age between 55 years and 80 years * unilateral internal carotid artery stenotic degree ≥ 70% * right-hand-dominant * free of dementia, and depression * modified Rankin Scale: 0 or 1 * education ≥6 years * obtained written informed consent. Exclusion criteria: * contralateral internal carotid artery stenosis ≥ 50% * posterior circulation diseases * MMSE \< 26, which is a cut-off value for mild cognitive impairment * severe systemic diseases and neuropsychiatric diseases (such as congestive heart failure) * any contraindications for MRI scan (e.g., metal implants) * Non atherosclerotic stenosis, such as dissection, vasculitis.

Conditions

Timeline

Start date
2021-12-01
Primary completion
2022-06-30
Completion
2022-07-01
First posted
2022-03-23
Last updated
2022-03-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05292729. Inclusion in this directory is not an endorsement.